Schizoaffective Disorder News and Research

RSS

Study finds discharge against medical advice as predictor of readmissions in heart attack patients

In a new study led by Keele University researchers found discharge against medical advice as the strongest predictor of 30-day unplanned readmissions in heart attack patients.

18 Jul 2018

Nitrate-cured meats may contribute to mania, study finds

An analysis of more than 1,000 people with and without psychiatric disorders has shown that nitrates-chemicals used to cure meats such as beef jerky, salami, hot dogs and other processed meat snacks-may contribute to mania, an abnormal mood state. Mania is characterized by hyperactivity, euphoria and insomnia.

18 Jul 2018

Mobile health intervention for people with serious mental illness as effective as clinic-based treatment

A mobile health intervention was found to be as effective as a clinic-based group intervention for people with serious mental illness in a new study published online today in Psychiatric Services.

25 May 2018

Web-based therapies increase likelihood of people with severe mental illness finding work

Patients living with severe mental illness are being helped to return to work courtesy of new research from Sydney's Westmead Institute for Medical Research.

11 Oct 2017

In Texas, people with mental illness find work helping peers

Recovery coaches and peer mentors — known in Alcoholics Anonymous as “sponsors” — have for decades helped those addicted to alcohol or drugs.

13 Jul 2017

New drug can reduce tardive dyskinesia in patients with schizophrenia, mood disorder

Antipsychotic treatment can cause involuntary movements such as lip smacking, tongue protrusions and excessive eye blinking. These movements typically occur after more than 3 months of treatment and are called tardive dyskinesia.

7 Apr 2017

Neurocrine Biosciences reports net loss of $29.3 million for fourth quarter 2015

Neurocrine Biosciences, Inc. today announced its financial results for the quarter and year ended December 31, 2015.

12 Feb 2016

Biotypes can identify distinct subgroups of psychosis

Three biomarker-based categories, called biotypes, outperformed traditional diagnoses, such as schizophrenia and bipolar disorder with psychosis, in sorting psychosis cases into distinct subgroups on the basis of brain biology, report researchers funded by the National Institutes of Health.

9 Dec 2015

UGA researchers identify biological markers for mental disorders

A team of researchers led by faculty at the University of Georgia has identified a number of biological markers that make it possible to classify mental disorders with greater precision. Their findings, published today in the American Journal of Psychiatry, may one day lead to improved diagnostics and treatments for those suffering from mental illness.

9 Dec 2015

Neurocrine Biosciences announces positive data from NBI-98854 Phase III trial in tardive dyskinesia

Neurocrine Biosciences, Inc. announced today that NBI-98854, a highly selective small molecule VMAT2 inhibitor, showed a statistically significant reduction in tardive dyskinesia during the six weeks of placebo-controlled treatment in the Kinect 3 clinical trial. This Phase III trial included moderate to severe tardive dyskinesia patients with underlying schizophrenia, schizoaffective disorder, bipolar or major depressive disorder.

8 Oct 2015

Mylan releases generic version of Invega in the U.S.

Mylan N.V. today announced the U.S. launch of Paliperidone Extended-Release Tablets 1.5 mg, 3 mg, 6 mg and 9 mg, the generic version of Janssen's Invega.

28 Sep 2015

Physicians may now have tools to predict people at greater risk of attempting suicide

People being treated for bipolar disorder and other psychiatric illnesses are at greater risk of attempting suicide, but physicians may now have tools to predict which of those individuals will attempt it and intervene early to prevent such tragedies from occurring.

18 Aug 2015

Low birth weight, preterm birth increase schizophrenia risk in individuals with 22q11.2 deletion syndrome

Low birth weight and preterm birth appear to increase the risk of schizophrenia among individuals with a genetic condition called the 22q11.2 deletion syndrome, a new study from the Centre for Addiction and Mental Health (CAMH) shows.

14 Aug 2015

Neurocrine completes enrollment in Phase III clinical trial of NBI-98854 in tardive dyskinesia patients

Neurocrine Biosciences, Inc. announced today that it has recently completed subject randomization of the Phase III clinical trial (Kinect 3 Study) of its proprietary Vesicular Mono-Amine Transporter 2 (VMAT2) compound NBI-98854 in tardive dyskinesia patients.

13 Aug 2015

Virtual human helps veterans with PTSD, people with mental illness build job interview skills

Finding a job is difficult for veterans with posttraumatic stress disorder (PTSD) and individuals with severe mental illness, who have high unemployment rates even though many want to work.

1 Jul 2015

New study finds that some immigrants, refugees in Ontario at higher risk of psychotic disorders

Immigrants from the Caribbean and Bermuda, as well as refugees from East Africa and South Asia, have a 1.5 to 2 times higher risk of psychotic disorders compared to the general population of Ontario, Canada, according to a new study by researchers at the Institute for Clinical Evaluative Sciences and the Centre for Addiction and Mental Health.

12 May 2015

TSRI scientists find molecular trigger of schizophrenia-like behaviors and brain changes

According to the World Health Organization, more than 21 million people worldwide suffer from schizophrenia, a severe psychiatric disorder that can cause delusions and hallucinations and lead to increased risk of suicide...

8 Apr 2015

Johnson & Johnson announces sales of $18.3 billion for Q4 2014

Johnson & Johnson today announced sales of $18.3 billion for the fourth quarter of 2014, a decrease of 0.6% as compared to the fourth quarter of 2013. Operational results increased 3.9% and the negative impact of currency was 4.5%. Domestic sales increased 7.4%.

20 Jan 2015

CET ‘feasible’ in schizophrenia patients with substance misuse

Patients with schizophrenia and comorbid substance abuse diagnoses are able to benefit from cognitive enhancement therapy, preliminary research suggests.

7 Jan 2015

Health promotion program reduces cardiovascular risk in obese people with serious mental illness

A health promotion program, called In SHAPE, specifically designed for people with serious mental illness, produced more fit participants and significant weight loss than a control group where participants only received a gym membership.

18 Dec 2014